Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | BCHE | P06276 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21341337 | 0.84 | KCNH2 (0.33) | KCNH2 | |
| SCHEMBL24943617 | 0.76 | ALDH1A1 (0.36) | KCNH2 | |
| SCHEMBL21341731 | 0.72 | KCNH2 (0.33) | KCNH2 | |
| SCHEMBL4026771 | 0.67 | HTR1D (0.41) | KCNH2 | |
| SCHEMBL24943824 | 0.62 | CCR9 (0.39) | KCNH2 | |
| SCHEMBL21341334 | 0.59 | CCR9 (0.39) | KCNH2 | |
| SCHEMBL23022497 | 0.59 | CYP2D6 (0.40) | — | |
| SCHEMBL20618778 | 0.59 | KCNH2 (0.41) | KCNH2 | |
| SCHEMBL16418629 | 0.59 | KCNH2 (0.41) | KCNH2 | |
| SCHEMBL21341616 | 0.59 | CCR9 (0.38) | KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220378743-A1 | METHOD FOR TREATING FATTY LIVER DISEASE AND/OR STEATOHEPATITIS | BEIJING TIDE PHARMACEUTICAL CO., LTD. (CN) | 2022-12-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220378743-A1 | METHOD FOR TREATING FATTY LIVER DISEASE AND/OR STEATOHEPATITIS | SLC10A1, CYP7A1, FABP1 | KCNH2 4488/4885BCHE 684/4885ACHE 2606/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.